The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Open science saves lives: lessons from the COVID-19 pandemic
Open accessPublished version of a preprint
Abstract
In the last decade Open Science principles have been successfully advocated for and are being slowly adopted in different research communities. In response to the COVID-19 pandemic many publishers and researchers have sped up their adoption of Open Science practices, sometimes embracing them fully and sometimes partially or in a sub-optimal manner. In this article, we express concerns about the violation of some of the Open Science principles and its potential impact on the quality of research output. We provide evidence of the misuses of these principles at different stages of the scientific process. We call for a wider adoption of Open Science practices in the hope that this work will encourage a broader endorsement of Open Science principles and serve as a reminder that science should always be a rigorous process, reliable and transparent, especially in the context of a pandemic where research findings are being translated into practice even more rapidly. We provide all data and scripts at https://osf.io/renxy/ .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
1,500 scientists lift the lid on reproducibility
Baker, M. (2016) · Nature · doi:10.1038/533452a · Cited by 4,209
A manifesto for reproducible science
Munafò, M. R., Nosek, B. A., Bishop, D. V. M., Button, K. S., Chambers, C. D., Percie du Sert, N., Simonsohn, U., Wagenmakers, E.-J., Ware, J. J., & Ioannidis, J. P. A. (2017) · Nature Human Behaviour · doi:10.1038/s41562-016-0021 · Cited by 3,397
The preregistration revolution
Nosek, B. A., Ebersole, C. R., DeHaven, A. C., & Mellor, D. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708274114 · Cited by 1,998
Fanelli, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005738 · Cited by 1,911 · cited 1×
“Considering that data fabrication and/or falsification has been observed in the scientific community and its frequency probably underestimated [86], some have suggested [15] that the policy of “sharing data upon request” is not enough.”
BackgroundObservational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2012410 · Cited by 1,625
Nosek (2012) · doi:10.1177/1745691612459058 · Cited by 1,301
Best practices in data analysis and sharing in neuroimaging using MRI
Nichols, T. E., Das, S., Eickhoff, S. B., Evans, A. C., Glatard, T., Hanke, M., Kriegeskorte, N., Milham, M. P., Poldrack, R. A., Poline, J.-B., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4500 · Cited by 714
Fraser, N., Brierley, L., Dey, G., Polka, J. K., Pálfy, M., Nanni, F., & Coates, J. A. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3000959 · Cited by 555 · cited 4×
“However, Fraser et al [101] found that COVID-19 preprints were more commented (on preprint platforms) than non COVID-19 preprints.”
BackgroundResultInfluentialSumner, P., Vivian-Griffiths, S., Boivin, J., Williams, A., Venetis, C. A., Davies, A., Ogden, J., Whelan, L., Hughes, B., Dalton, B., et al. (2014) · BMJ · doi:10.1136/bmj.g7015 · Cited by 489 · cited 1×
“, [110, 111, 112]) and can therefore directly exacerbate the spread of non-peer-reviewed findings if their communications are based on preprints.”
Background
Research works printed but not linked: 81
- Glasziou PP, Sanders S, Hoffmann T. Waste in covid-19 research. BMJ. 2020; 369:m1847. https://doi.org/10.1136/bmj.m1847. · DOI · Paper page
- Yeo-Teh NSL, Tang BL. An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19). Accountability Res. 2020:1–7. https://doi.org/10.1080/08989621.2020.1782203. PMID: 32573274. · DOI
- Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. The Lancet. 2009; 374(9683):86–9. https://doi.org/10.1016/S0140-6736(09)60329-9. · DOI · Paper page
- Allen C, Mehler DMA. Open science challenges, benefits and tips in early career and beyond. PLoS Biol. 2019; 17(5):1–14. https://doi.org/10.1371/journal.pbio.3000246. · DOI · Paper page
- Cockburn A, Dragicevic P, Besançon L, Gutwin C. Threats of a replication crisis in empirical computer science. Commun ACM. 2020; 63(8):70–9. https://doi.org/10.1145/3360311. · DOI
- Smaldino PE, Turner MA, Contreras Kallens PA. Open science and modified funding lotteries can impede the natural selection of bad science. R Soc Open Sci. 2019; 6(7):190194. https://doi.org/10.1098/rsos.190194. · DOI
- Masuzzo P, Martens L. Do you speak open science? Resources and tips to learn the language. PeerJ Preprints. 2017; 5:2689–1. https://doi.org/10.7287/peerj.preprints.2689v1. · doi:10.7287/peerj.preprints.2689v1
- Watson M. When will ‘open science’ become simply ‘science’?Genome Biol. 2015; 16(1):1–3. https://doi.org/10.1186/s13059-015-0669-2. · DOI
- Sarabipour S, Debat HJ, Emmott E, Burgess SJ, Schwessinger B, Hensel Z. On the value of preprints: An early career researcher perspective. PLoS Biol. 2019; 17(2):1–12. https://doi.org/10.1371/journal.pbio.3000151. · DOI · Paper page
- Goecks J, Nekrutenko A, Taylor J, The Galaxy Team. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 2010; 11(8):86. https://doi.org/10.1186/gb-2010-11-8-r86. · DOI · Paper page
- Besançon L, Rönnberg N, Löwgren J, Tennant JP, Cooper M. Open up: a survey on open and non-anonymized peer reviewing. Res Integr Peer Rev. 2020; 5(1):1–11. https://doi.org/10.1186/s41073-020-00094-z. · DOI
- Snell L, Spencer J. Reviewers’ perceptions of the peer review process for a medical education journal. Med Educ. 2005; 39(1):90–7. https://doi.org/10.1111/j.1365-2929.2004.02026.x. · DOI
- COVID-19 resources for librarians, campuses and health professionals (March 24, 2020). https://www.elsevier.com/connect/coronavirus-initiatives. (2020, Accessed 20 April 2021).
- Fraser N, Brierley L, Dey G, Polka JK, Pálfy M, Coates JA. Preprinting a pandemic: the role of preprints in the COVID-19 pandemic. bioRxiv. 2020. https://doi.org/10.1101/2020.05.22.111294. · DOI
- Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of covid-19: a multinational registry analysis. The Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)31180-6. · DOI · Paper page
- Wolkewitz M, Puljak L. Methodological challenges of analysing COVID-19 data during the pandemic. BMC Med Res Methodol. 2020; 20(81). https://doi.org/10.1186/s12874-020-00972-6. · DOI
- Rosendaal FR. Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al. 2010. Int J Antimicrob Agents. 2020; 56(1):106063. https://doi.org/10.1016/j.ijantimicag.2020.106063. · DOI
- Is France’s president fueling the hype over an unproven coronavirus treatment? 2020. https://www.sciencemag.org https: //www.sciencemag.org/news/2020/04/france-s-president-fueling-hype-over-unproven-coronavirus-treatment. Accessed 20 July 2020.
- Ledford H. Coronavirus shuts down trials of drugs for multiple other diseases. Nature. 2020; 580(7801):15–7. https://doi.org/10.1038/d41586-020-00889-6. · DOI
- Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain J-M, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949. https://doi.org/10.1016/j.ijantimicag.2020.105949. · DOI · Paper page
- Xafis V, Schaefer GO, Labude MK, Zhu Y, Hsu LY. The perfect moral storm: Diverse ethical considerations in the COVID-19 pandemic. Asian Bioeth Rev. 2020; 46(12):803–7. https://doi.org/10.1007/s41649-020-00125-3. · DOI
- Nguyen LS, Dolladille C, Drici M-D, Fenioux C, Alexandre J, Mira J-P, Moslehi JJ, Roden DM, Funck-Brentano C, Salem J-E. Cardiovascular toxicities associated with hydroxychloroquine and azithromycin. Circulation. 2020; 142(3):303–5. https://doi.org/10.1161/CIRCULATIONAHA.120.048238. · DOI
- Bramstedt KA. The carnage of substandard research during the COVID-19 pandemic: a call for quality. J Med Ethics. 2020; 46:803–7. https://doi.org/10.1136/medethics-2020-106494. · DOI · Paper page
- Cockburn A, Gutwin C, Dix A. Hark no more: On the preregistration of chi experiments. In: Proceedings of the 2018 CHI Conference on Human Factors in Computing Systems CHI ’18. New York, NY, USA: Association for Computing Machinery: 2018. p. 1–12. https://doi.org/10.1145/3173574.3173715. · DOI
- Reveiz L, Cortés-Jofré M, Asenjo Lobos C, Nicita G, Ciapponi A, Garcìa-Dieguez M, Tellez D, Delgado M, Solà I, Ospina E. Influence of trial registration on reporting quality of randomized trials: Study from highest ranked journals. J Clin Epidemiol. 2010; 63(11):1216–22. https://doi.org/10.1016/j.jclinepi.2010.01.013. · DOI
- Dodd LE, Follmann D, Wang J, Koenig F, Korn LL, Schoergenhofer C, Proschan M, Hunsberger S, Bonnett T, Makowski M, Belhadi D, Wang Y, Cao B, Mentre F, Jaki T. Endpoints for randomized controlled clinical trials for COVID-19 treatments. Clin Trials. 2020; 17(5):472–82. https://doi.org/10.1177/1740774520939938. · DOI
- Wagenmakers E-J, Dutilh G, Sarafoglou A. The creativity-verification cycle in psychological science: New methods to combat old idols. Perspect Psychol Sci. 2018; 13(4):418–27. https://doi.org/10.1177/1745691618771357. PMID: 29961413. · DOI
- Wiseman R, Watt C, Kornbrot D. Registered reports: an early example and analysis. PeerJ. 2019; 7:6232. https://doi.org/10.7717/peerj.6232. · DOI
- Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624):806–8. https://doi.org/10.1136/bmj.39335.541782.AD. · DOI · Paper page
- LeBlanc AG, Barnes JD, Saunders TJ, Tremblay MS, Chaput J-P. Scientific sinkhole: The pernicious price of formatting. PLoS ONE. 2019; 14(9):1–7. https://doi.org/10.1371/journal.pone.0223116. · DOI
- Pain E. Meet Octopus, a new vision for scientific publishing. https://www.sciencemag.org/careers/2018/11/meet-octopus-new-vision-scientific-publishing. Accessed 20 July 2020. · doi:10.1126/science.caredit.aav9309
- Palayew A, Norgaard O, Safreed-Harmon K, Andersen TH, Rasmussen LN, Lazarus JV. Pandemic publishing poses a new covid-19 challenge. Nat Hum Behav. 2020:666–9. https://doi.org/10.1038/s41562-020-0911-0. · DOI · Paper page
- Pederson T. Publishing coronavirology: Peering into peer(less?) review. FASEB J. 2020; 34(8):9825–7. https://doi.org/10.1096/fj.202001592. · DOI
- Journal of Critical Care, COVID-19 Update. Elsevier. https://www.journals.elsevier.com/journal-of-critical-care/covid-19. Accessed 20 July 2020.
- COVID-19 Articles Accepted for Fast-Track Publication in Psychological Science. Psychological Science. SAGE. https://journals.sagepub.com/page/pss/covid-19. Accessed 20 July 2020.
- Homolak J, Kodvanj I, Virag D. Preliminary analysis of COVID-19 academic information patterns: a call for open science in the times of closed borders. Scientometrics. 2020; 124:2687–701. https://doi.org/10.1007/s11192-020-03587-2. · DOI · Paper page
- Aviv A. Telomeres and COVID-19. FASEB J. 2020; 34(6):7247–52. https://doi.org/10.1096/fj.202001025. · DOI · Paper page
- Committee on Publication Ethics. A short guide to ethical editing for new editors. https://doi.org/10.24318/cope.2019.1.8. https://publicationethics.org/node/19871. · doi:10.24318/cope.2019.1.8
- Risch HA. Opinion: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis. Am J Epidemiol. 2020; 189(11):1218–26. https://doi.org/10.1093/aje/kwaa093. · DOI
- Fox MP, D’Agostino McGowan L, James BD, Lessler J, Mehta SH, Murray EJ. Concerns About the Special Article on Hydroxychloroquine and Azithromycin in High Risk Outpatients with COVID-19 by Dr. Harvey Risch. Am J Epidemiol. 2021; 190(4):491–5. https://doi.org/10.1093/aje/kwaa189. · DOI
- Machiels JD, Bleeker-Rovers CP, ter Heine R, Rahamat-Langendoen J, de Mast Q, ten Oever J, Bousema T, van Crevel R, Wertheim HF. Reply to Gautret et al.: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?Int J Antimicrob Agents. 2020; 56(1):106056. https://doi.org/10.1016/j.ijantimicag.2020.106056. · DOI
- Voss A, Coombs G, Unal S, Saginur R, Hsueh P-R. Publishing in face of the COVID-19 pandemic. Int J Antimicrob Agents. 2020; 56(1):106081. https://doi.org/10.1016/j.ijantimicag.2020.106081. · doi:10.1016/j.ijantimicag.2020.106081
- Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Retraction: Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. 2020; 382(26):2582. https://doi.org/10.1056/NEJMc2021225. · DOI · Paper page
- Mahase E. Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk. BMJ. 2020; 369. https://doi.org/10.1136/bmj.m2126. · doi:10.1136/bmj.m2126
- Hardwicke TE, Goodman SN. How often do leading biomedical journals use statistical experts to evaluate statistical methods? the results of a survey. PLoS ONE. 2020; 15(10):1–12. https://doi.org/10.1371/journal.pone.0239598. · DOI
- The BMJ Editorial Board. https://www.bmj.com/about-bmj/editorial-staff. (Accessed 15 July 2020).
- Pardo R, Algara M, Montero-Fernández MA, Sanz X, Vernet M, Rodríguez N, Andrés-Luna R, Piñero A, Ciérvide R, Córdoba R, et al.Diagnosis and locoregional treatment of patients with breast cancer during the COVID-19 pandemic. Revista de Senologia y Patologia Mamaria. 2020; 33(2):61–7. https://doi.org/10.1016/j.senol.2020.04.002. · doi:10.1016/j.senol.2020.04.002
- Review Commons. 2020. https://www.reviewcommons.org/about/.
- Pucker B, Schilbert HM, Schumacher SF. Integrating Molecular Biology and Bioinformatics Education. J Integr Bioinforma. 2019; 16(3). https://doi.org/10.1515/jib-2019-0005. · DOI
- Jansen Y, Hornbaek K, Dragicevic P. What Did Authors Value in the CHI’16 Reviews They Received? In: Proceedings of the 2016 CHI Conference Extended Abstracts on Human Factors in Computing Systems: 2016. p. 596–608. https://doi.org/10.1145/2851581.2892576. · doi:10.1145/2851581.2892576
- Squazzoni F, Grimaldo F, Marušić A. Publishing: Journals could share peer-review data. Nature. 2017; 546:352. · DOI
- McNutt M. Journals unite for reproducibility. Nature. 2014; 515:7. https://doi.org/10.1038/515007a. · DOI
- Blumzon CFI, Pănescu AT. Data Storage. Cham: Springer; 2020, pp. 277–97. https://doi.org/10.1007/164\_2019\_28. · doi:10.1007/164_2019_28
- Asendorpf JB, Conner M, De Fruyt F, De Houwer J, Denissen JJA, Fiedler K, Fiedler S, Funder DC, Kliegl R, Nosek BA, Perugini M, Roberts BW, Schmitt M, van Aken MAG, Weber H, Wicherts JM. Recommendations for increasing replicability in psychology. Eur J Personal. 2013; 27(2):108–19. https://doi.org/10.1002/per.1919. · DOI · Paper page
- Begley CG, Ioannidis JP. Reproducibility in science: improving the standard for basic and preclinical research. Circ Res. 2015; 116(1):116–26. https://doi.org/10.1161/CIRCRESAHA.114.303819. · DOI · Paper page
- Li R, von Isenburg M, Levenstein M, Neumann S, Wood J, Sim I. Covid-19 trials: declarations of data sharing intentions at trial registration and at publication. Trials. 2021; 22(153). https://doi.org/10.1186/s13063-021-05104-z. · DOI
- Johnson AE, Pollard TJ, Shen L, Li-Wei HL, Feng M, Ghassemi M, Moody B, Szolovits P, Celi LA, Mark RG. MIMIC-III, a freely accessible critical care database. BSci data. 2016; 3. https://doi.org/10.1038/sdata.2016.35. · DOI · Paper page
- Easterbrook SM. Open code for open science?Nat Geosci. 2014; 7(11):779–81. https://doi.org/10.1038/ngeo2283. · DOI
- Gilroy SP, Kaplan BA. Furthering open science in behavior analysis: An introduction and tutorial for using GitHub in research. Perspect Behav Sci. 2019; 42(3):565–81. https://doi.org/10.1007/s40614-019-00202-5. · DOI
- Perkel J. Democratic databases: science on GitHub. Nature. 2016; 538(7623):127–8. https://doi.org/10.1038/538127a. · DOI
- Wiley’s Data Sharing Policies. https://authorservices.wiley.com/author-resources/Journal-Authors/open-access/data-sharing-citation/data-sharing-policy. html. (Accessed 15 July 2020).
- Murcott THL, Williams A. The challenges for science journalism in the UK. Prog Phys Geogr: Earth Environ. 2013; 37(2):152–60. https://doi.org/10.1177/0309133312471285. · DOI
- Fry NK, Marshall H, Mellins-Cohen T. In praise of preprints. Microb Genomics. 2019; 5(4). https://doi.org/10.1099/mgen.0.000259. · DOI
- Kwon D. How swamped preprint servers are blocking bad coronavirus research. Nature. 2020. https://doi.org/10.1038/d41586-020-01394-6. · DOI · Paper page
- Johansson MA, Reich NG, Meyers LA, Lipsitch M. Preprints: An underutilized mechanism to accelerate outbreak science. PLoS Med. 2018; 15(4):1002549. https://doi.org/10.1371/journal.pmed.1002549. · DOI · Paper page
- Gautret P, Lagier J-C, Parola P, Hoang VT, Medded L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Esteves Vieira V, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain J-M, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949. https://doi.org/10.1016/j.ijantimicag.2020.105949. · DOI · Paper page
- Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020; 16(7):659–66. https://doi.org/10.1080/1744666X.2020.1792778. PMID: 32620062. · DOI
- Bae S, Kim MC, Kim JY, Cha HH, Lim JS, Jung J, Kim MJ, Oh DK, Lee M-K, Choi S-H, Sung M, Hong SB, Chung JW, Kim SH. Effectiveness of surgical and cotton masks in blocking SARS–CoV-2: a controlled comparison in 4 patients. Ann Intern Med. 2020; 173(1):22–3. https://doi.org/10.7326/M20-1342. PMID: 32251511. · DOI · Paper page
- Sheldon T. Preprints could promote confusion and distortion. Nature. 2018; 559(7714):445–6. https://doi.org/10.1038/d41586-018-05789-4. · DOI
- Dumas-Mallet E, Smith A, Boraud T, Gonon F. Scientific uncertainty in the press: How newspapers describe initial biomedical findings. Sci Commun. 2018; 40(1):124–41. https://doi.org/10.1177/1075547017752166. · DOI
- Meier K, Schützeneder J. Bridging the gaps: Transfer between scholarly research and newsrooms in journalism education–toward an evidence-based practice in an age of post-truth and state of flux. Journal Mass Commun Educ. 2019; 74(2):199–211. https://doi.org/10.1177/1077695819830021. · doi:10.1177/1077695819830021
- Miranda GF, Vercellesi L, Bruno F. Information sources in biomedical science and medical journalism: methodological approaches and assessment. Pharmacol Res. 2004; 50(3):267–72. https://doi.org/10.1016/j.phrs.2003.12.021. · DOI
- Peláez AL, Díaz JA. Science, technology and democracy: Perspectives about the complex relation between the scientific community, the scientific journalist and public opinion. Soc Epistemol. 2007; 21(1):55–68. https://doi.org/10.1080/02691720601125548. · doi:10.1080/02691720601125548
- Chalaud D, Aghan D, Otindo V, Bennett A, Baldet T. Ebola: improving science-based communication and local journalism. Lancet. 2015; 386(10009):2139. https://doi.org/10.1016/S0140-6736(15)01047-8. · doi:10.1016/s0140-6736(15)01047-8
- La V-P, Pham T-H, Ho M-T, Nguyen M-H, P Nguyen K-L, Vuong T-T, Nguyen H-KT, Tran T, Khuc Q, Ho M-T, Vuong Q-H. Policy response, social media science journalism for the sustainability of the public health system amid the COVID-19 outbreak: the Vietnam lessons. Sustainability. 2020; 12(7). https://doi.org/10.3390/su12072931. · DOI · Paper page
- Smeros P, Castillo C, Aberer K. Scilens: Evaluating the quality of scientific news articles using social media and scientific literature indicators. In: The World Wide Web Conference WWW ’19. New York, NY, USA: Association for Computing Machinery: 2019. p. 1747–58. https://doi.org/10.1145/3308558.3313657. · DOI
- Vraga EK, Tully M, Bode L. Empowering users to respond to misinformation about COVID-19. Media Commun. 2020; 8(2):475–9. https://doi.org/10.17645/mac.v8i2.3200. · DOI
- Jeschke JM, Lokatis S, Bartram I, Tockner K. Knowledge in the dark: scientific challenges and ways forward. FACETS. 2019; 4(1):423–41. https://doi.org/10.1139/facets-2019-0007. · DOI
- Kowalczyk O, Lautarescu A, Blok E, Dall’Aglio L, Westwood SJ. What senior academics can do to support reproducible and open research: a short, three-step guide. PsyArXiv. 2020. https://doi.org/10.31234/osf.io/jyfr7. · DOI
- Thorp HH. Science has always been political. Science. 2020; 369(6501):227. https://doi.org/10.1126/science.abd7628. · doi:10.1126/science.abd7628
- Kickbusch I. Politics or technocracy – what next for global health?; comment on navigating between stealth advocacy and unconscious dogmatism: The challenge of researching the norms, politics and power of global health. Int J Health Policy Manag. 2016; 5(3):201–4. https://doi.org/10.15171/ijhpm.2015.209. · doi:10.15171/ijhpm.2015.209
Cited by
Fraser, N., Brierley, L., Dey, G., Polka, J. K., Pálfy, M., Nanni, F., & Coates, J. A. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3000959 · Cited by 555
“An even greater adoption of open science principles has recently been suggested as one method to counter the misuse of preprints and peer-reviewed articles [24]; this remains an increasingly important discourse.”
McIntosh, T. R., Susnjak, T., Liu, T., Watters, P., Xu, D., Liu, D., & Halgamuge, M. N. (2025) · Technologies · doi:10.3390/technologies13020051 · Cited by 102
“The surge in preprints may lead to the propagation of unvalidated or biased information, as these studies do not undergo the rigorous scrutiny and potential retraction typical of peer-reviewed publications [16], [17].”
BackgroundCorrection of scientific literature: Too little, too late!
Besançon, L., Bik, E., Heathers, J., & Meyerowitz-Katz, G. (2022) · PLOS Biology · doi:10.1371/journal.pbio.3001572 · Cited by 46
Self-citationSong, H., Markowitz, D. M., & Taylor, S. H. (2022) · Journal of Communication · doi:10.1093/joc/jqac017 · Cited by 41
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Kapp, P., Esmail, L., Ghosn, L., Ravaud, P., & Boutron, I. (2022) · BMC Medicine · doi:10.1186/s12916-022-02567-y · Cited by 25
“Some researchers, decision-makers, funders, and editors raised concerns related to the risk of disseminating reports that were not peer-reviewed [8, 13].”
BackgroundInfluential
Metadata
- Authors
- Besançon, L., Peiffer-Smadja, N., Segalas, C., Jiang, H., Masuzzo, P., Smout, C., Billy, E., Deforet, M., & Leyrat, C.
- Venue
- BMC Medical Research Methodology
- Published
- 2021-06-05
- Volume
- 21
- Issue
- 1
- Pages
- 117-117
- ISSN
- 1471-2288 (ISSN-L)
- OpenAlex
- W3171995498
- Cited by
- 249
- References
- 24
- FWCI
- 43.05
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Open science saves lives: lessons from the COVID-19 pandemic. https://app.cochat.ai/papers/10.1186/s12874-021-01304-y
- The paper
- Besançon, L., Peiffer-Smadja, N., Segalas, C., Jiang, H., Masuzzo, P., Smout, C., Billy, E., Deforet, M., & Leyrat, C. (2021). Open science saves lives: lessons from the COVID-19 pandemic. BMC Medical Research Methodology. https://doi.org/10.1186/s12874-021-01304-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.